OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responses
Felix Bayerl, Philippa Meiser, Sainitin Donakonda, et al.
Immunity (2023) Vol. 56, Iss. 6, pp. 1341-1358.e11
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

The cancer-immunity cycle: Indication, genotype, and immunotype
Ira Mellman, Daniel S. Chen, Thomas Powles, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2188-2205
Open Access | Times Cited: 351

Dendritic cells as orchestrators of anticancer immunity and immunotherapy
Ignacio Heras‐Murillo, Irene Adán‐Barrientos, Miguel Á. Galán, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 4, pp. 257-277
Closed Access | Times Cited: 102

Dendritic cells as shepherds of T cell immunity in cancer
Mikaël J. Pittet, Mauro Di Pilato, Christopher Garris, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2218-2230
Open Access | Times Cited: 92

A distinct stimulatory cDC1 subpopulation amplifies CD8+ T cell responses in tumors for protective anti-cancer immunity
Philippa Meiser, Moritz Knolle, Anna Hirschberger, et al.
Cancer Cell (2023) Vol. 41, Iss. 8, pp. 1498-1515.e10
Open Access | Times Cited: 86

Ferroptosis in health and disease
Carsten Berndt, Hamed Alborzinia, Vera Skafar Amen, et al.
Redox Biology (2024) Vol. 75, pp. 103211-103211
Open Access | Times Cited: 65

The hallmarks of cancer immune evasion
Claudia Galassi, Timothy A. Chan, Ilio Vitale, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1825-1863
Closed Access | Times Cited: 57

Cancer cell metabolism and antitumour immunity
Mara De Martino, Jeffrey C. Rathmell, Lorenzo Galluzzi, et al.
Nature reviews. Immunology (2024) Vol. 24, Iss. 9, pp. 654-669
Open Access | Times Cited: 49

PGE2 limits effector expansion of tumour-infiltrating stem-like CD8+ T cells
Sebastian Lacher, Janina Dörr, Gustavo Pereira de Almeida, et al.
Nature (2024) Vol. 629, Iss. 8011, pp. 417-425
Open Access | Times Cited: 44

Metabolic reprogramming in the tumor microenvironment of liver cancer
Jian Lin, Dongning Rao, Mao Zhang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 41

Nanotechnology Reprogramming Metabolism for Enhanced Tumor Immunotherapy
Yangkai Zhou, Jing Yuan, Ke Xu, et al.
ACS Nano (2024) Vol. 18, Iss. 3, pp. 1846-1864
Closed Access | Times Cited: 20

Prostaglandin E2 in the Tumor Microenvironment, a Convoluted Affair Mediated by EP Receptors 2 and 4
Ana Santiso, Ákos Heinemann, Julia Kargl
Pharmacological Reviews (2024) Vol. 76, Iss. 3, pp. 388-413
Open Access | Times Cited: 16

Cross-priming in cancer immunology and immunotherapy
Carlos Luri‐Rey, Álvaro Teijeira, Stefanie K. Wculek, et al.
Nature reviews. Cancer (2025)
Closed Access | Times Cited: 2

Celecoxib Augments Paclitaxel-Induced Immunogenic Cell Death in Triple-Negative Breast Cancer
Xiaohui Qian, Yang Huang, Ziqiang Ye, et al.
ACS Nano (2024) Vol. 18, Iss. 24, pp. 15864-15877
Closed Access | Times Cited: 10

Pathological and pharmacological functions of the metabolites of polyunsaturated fatty acids mediated by cyclooxygenases, lipoxygenases, and cytochrome P450s in cancers
Yi-Wen Meng, Jun‐Yan Liu
Pharmacology & Therapeutics (2024) Vol. 256, pp. 108612-108612
Closed Access | Times Cited: 9

Convergent inducers and effectors of T cell paralysis in the tumour microenvironment
Douglas Hanahan, Olivier Michielin, Mikaël J. Pittet
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 9

Cancer cells impair monocyte-mediated T cell stimulation to evade immunity
Anais Elewaut, Guillem Estivill, Felix Bayerl, et al.
Nature (2024)
Open Access | Times Cited: 9

Innate Immune Cells in Tumour Microenvironment: A New Frontier in Cancer Immunotherapy
Changhui Li, Xinyu Yu, Xinyan Han, et al.
iScience (2024) Vol. 27, Iss. 9, pp. 110750-110750
Open Access | Times Cited: 8

Tumor secretome shapes the immune landscape during cancer progression
Jianqiang Yang, Sijia Tang, Nabil F. Saba, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 1

Linking macrophage metabolism to function in the tumor microenvironment
Robbie Jin, Luke Neufeld, Tracy L. McGaha
Nature Cancer (2025)
Closed Access | Times Cited: 1

Dysfunction of dendritic cells in tumor microenvironment and immunotherapy
Jie Chen, Yu-Hang Duan, Junye Che, et al.
Cancer Communications (2024) Vol. 44, Iss. 9, pp. 1047-1070
Open Access | Times Cited: 7

Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy
Christine Moussion, Lélia Delamarre
Seminars in Immunology (2023) Vol. 71, pp. 101848-101848
Closed Access | Times Cited: 15

Metabolic rewiring and communication in cancer immunity
Nicole M. Chapman, Hongbo Chi
Cell chemical biology (2024) Vol. 31, Iss. 5, pp. 862-883
Open Access | Times Cited: 5

Effects of Ethanol Concentrations on Primary Structural and Bioactive Characteristics of Dendrobium officinale Polysaccharides
Juan Yu, Long Yan, Jinyue Chi, et al.
Nutrients (2024) Vol. 16, Iss. 6, pp. 897-897
Open Access | Times Cited: 5

Multimodal targeting chimeras enable integrated immunotherapy leveraging tumor-immune microenvironment
Lin Feng, Shenyi Yin, Zijian Zhang, et al.
Cell (2024)
Closed Access | Times Cited: 5

Page 1 - Next Page

Scroll to top